When should you consider allergen immunotherapy?

Rana S. Bonds, J. Andrew Grant, William Calhoun

Research output: Contribution to journalArticle

Abstract

Allergen immunotherapy is recommended for patients with insect venom hypersensitivity and those who have both allergic rhinitis and allergic asthma. Consider immunotherapy for patients whose allergic rhinitis is insufficiently controlled by medication and avoidance measures. A standard immunotherapy schedule entails injections of increasing concentrations of allergens once or twice weekly during a buildup phase. Maintenance dosing is continued for 3 to 5 years. Immunotherapy in patients with allergic rhinitis and/or conjunctivitis attributable to IgE-mediated mechanisms modifies the natural history of the disease, rather than just alleviating symptoms. Immunotherapy for children with allergic rhinitis may prevent asthma and reduce the risk of sensitivity to other allergens.

Original languageEnglish (US)
Pages (from-to)436-440
Number of pages5
JournalJournal of Respiratory Diseases
Volume28
Issue number10
StatePublished - Oct 2007

Fingerprint

Immunologic Desensitization
Immunotherapy
Allergens
Asthma
Allergic Conjunctivitis
Venoms
Immunoglobulin E
Insects
Appointments and Schedules
Hypersensitivity
Maintenance
Injections
Allergic Rhinitis

Keywords

  • Allergic asthma
  • Allergic rhinitis
  • Immunotherapy
  • Venom allergy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

When should you consider allergen immunotherapy? / Bonds, Rana S.; Grant, J. Andrew; Calhoun, William.

In: Journal of Respiratory Diseases, Vol. 28, No. 10, 10.2007, p. 436-440.

Research output: Contribution to journalArticle

Bonds, RS, Grant, JA & Calhoun, W 2007, 'When should you consider allergen immunotherapy?', Journal of Respiratory Diseases, vol. 28, no. 10, pp. 436-440.
Bonds, Rana S. ; Grant, J. Andrew ; Calhoun, William. / When should you consider allergen immunotherapy?. In: Journal of Respiratory Diseases. 2007 ; Vol. 28, No. 10. pp. 436-440.
@article{271528f9425c43249b86fb355cd1ed0c,
title = "When should you consider allergen immunotherapy?",
abstract = "Allergen immunotherapy is recommended for patients with insect venom hypersensitivity and those who have both allergic rhinitis and allergic asthma. Consider immunotherapy for patients whose allergic rhinitis is insufficiently controlled by medication and avoidance measures. A standard immunotherapy schedule entails injections of increasing concentrations of allergens once or twice weekly during a buildup phase. Maintenance dosing is continued for 3 to 5 years. Immunotherapy in patients with allergic rhinitis and/or conjunctivitis attributable to IgE-mediated mechanisms modifies the natural history of the disease, rather than just alleviating symptoms. Immunotherapy for children with allergic rhinitis may prevent asthma and reduce the risk of sensitivity to other allergens.",
keywords = "Allergic asthma, Allergic rhinitis, Immunotherapy, Venom allergy",
author = "Bonds, {Rana S.} and Grant, {J. Andrew} and William Calhoun",
year = "2007",
month = "10",
language = "English (US)",
volume = "28",
pages = "436--440",
journal = "Journal of Respiratory Diseases - For Pediatricians",
issn = "0194-259X",
publisher = "Cliggott Publishing Co.",
number = "10",

}

TY - JOUR

T1 - When should you consider allergen immunotherapy?

AU - Bonds, Rana S.

AU - Grant, J. Andrew

AU - Calhoun, William

PY - 2007/10

Y1 - 2007/10

N2 - Allergen immunotherapy is recommended for patients with insect venom hypersensitivity and those who have both allergic rhinitis and allergic asthma. Consider immunotherapy for patients whose allergic rhinitis is insufficiently controlled by medication and avoidance measures. A standard immunotherapy schedule entails injections of increasing concentrations of allergens once or twice weekly during a buildup phase. Maintenance dosing is continued for 3 to 5 years. Immunotherapy in patients with allergic rhinitis and/or conjunctivitis attributable to IgE-mediated mechanisms modifies the natural history of the disease, rather than just alleviating symptoms. Immunotherapy for children with allergic rhinitis may prevent asthma and reduce the risk of sensitivity to other allergens.

AB - Allergen immunotherapy is recommended for patients with insect venom hypersensitivity and those who have both allergic rhinitis and allergic asthma. Consider immunotherapy for patients whose allergic rhinitis is insufficiently controlled by medication and avoidance measures. A standard immunotherapy schedule entails injections of increasing concentrations of allergens once or twice weekly during a buildup phase. Maintenance dosing is continued for 3 to 5 years. Immunotherapy in patients with allergic rhinitis and/or conjunctivitis attributable to IgE-mediated mechanisms modifies the natural history of the disease, rather than just alleviating symptoms. Immunotherapy for children with allergic rhinitis may prevent asthma and reduce the risk of sensitivity to other allergens.

KW - Allergic asthma

KW - Allergic rhinitis

KW - Immunotherapy

KW - Venom allergy

UR - http://www.scopus.com/inward/record.url?scp=35948964879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35948964879&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 436

EP - 440

JO - Journal of Respiratory Diseases - For Pediatricians

JF - Journal of Respiratory Diseases - For Pediatricians

SN - 0194-259X

IS - 10

ER -